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A C C E P T E D M
A N U S C R I P T A C C E P T E D M A N U S C R I P T 3  However, further investigation in a multi-center trial using the current methods is not justified due to the lack of difference in the treatment effect of MDT within six weeks, with or without the use of the LUMOback for assisting postural correction.
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BACKGROUND
Low back pain (LBP) results in economic and healthcare burden throughout the world [1] . In patients with acute LBP (i.e. symptom duration <1 month), moderatequality evidence showed no clear differences between different exercise regimes [2] .
However, the following are also recommended with strong-evidence [3] : mechanical loading strategies in a specific direction resulting in centralization to be undertaken in patients with LBP with related (referred) lower extremity pain including acute LBP; and mechanical loading strategies in a specific direction resulting in improvement of symptoms and mobility of the back to be undertaken in patients with acute, subacute or chronic LBP. The specific direction resulting in centralization and/or improvement of symptoms and mobility is termed directional preference (DP). Therefore, exercise therapy with mechanical loading strategies in the DP is an evidence-based approach for all patients with LBP with or without referred pain.
A previous study suggested that individuals with LBP had more slouched habitual lumbopelvic posture than individuals without any history of LBP [4] .
Furthermore, an awkward posture, such as slouched posture, is a risk factor for LBP, and the risk increases when this posture is combined with prolonged sitting [5] .
Therefore, postural correction/education to maintain the lumbar lordosis is likely to be
important to enhance the treatment effect of exercise therapy in the DP, particularly for patients who have LBP with or without referred pain and a DP of lumbar extension.
Mechanical Diagnosis and Therapy (MDT) is one of the most commonly used physical therapy approaches for the management of LBP [6, 7] , which includes a biopsychosocial perspective [8] and puts an emphasis on patient education [9] . In patients with a DP for extension, MDT includes exercise therapy in the DP, such as extension in lying, and postural correction/education using a lumbar roll to avoid kyphotic lumbar posture with posterior pelvic tilt. Recent developments in wearable device technologies may also be useful for postural correction. The LUMOback (Lumo Bodytech Inc., Mountain View, CA, USA) device, which works on i-phone application, continuously monitors the pelvic position during everyday life and can provide realtime feedback to avoid a slouched posture using a vibration alert. Therefore, it was hypothesized that the treatment effect of MDT could be enhanced with the use of realtime feedback with the LUMOback in patients with a DP of lumbar extension. However, there has been no study using MDT with the LUMOback and it was considered prudent to undertake a pilot randomized control trial (RCT) before undertaking a full RCT.
The purpose of this study was to pilot the methods proposed to conduct a full RCT to investigate whether the treatment effect of MDT is enhanced with the LUMOback in patients with LBP and a DP of lumbar extension. In particular, the following aspects were investigated: 1) recruitment rate per month, 2) number of treatment sessions, 3) compliance rate of wearing the LUMOback, 4) adherence with treatment, 5) dropout rate and 6) stage of the MDT program at six weeks. The secondary purpose was to undertake a preliminary comparison in patient reportedoutcomes and to estimate the variability of these outcomes in this patient population.
METHODS
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Design
This study was a single-center assessor blinded parallel group RCT, where one group of interventions was MDT only (MDT group) and the other was MDT with realtime feedback using the LUMOback (MDT+LUMOback group). All patients provided written consent before data collection. The study design was approved by the institutional research ethics committee (XXXX) and pre-registered in the trial registration (UMIN000018380).
Patients
Patients were recruited via advertising in a local orthopedic clinic in XXX from In the MDT+LUMOback group, patients were asked to wear the LUMOback daily for the full 6-week of the intervention, except when playing water sports, taking a shower or sleeping. Detailed information about the LUMOback is found in a previous study [4] . Briefly, a threshold of 'very slouched' was considered clinically relevant in the MDT intervention [4] and thus a 'very slouched' posture which lasted for more than five seconds triggered feedback with LUMOback vibration.
Outcome measures proposed for the full trial
The treatment effect was assessed with a 7-point Global Rating of Change Scale (GRCS) (0=worse than ever, 1=much worsened, 2=slightly worsened, 3=no
change, 4=slightly improved, 5=much improved, 6=completely recovered). The GRCS were assessed at three and six weeks after the initial MDT session.
Secondary outcome measures
The current study included demographic and patient-reported measures, and objective measures. In the demographic and patient-reported measures, the following were assessed: 1) age and gender, 2) symptom information including pain location, pain intensity, pain duration, magnitude of disability, self-reporting functional limitations, and quality of life. In the objective measures, sagittal mobility of the trunk was assessed by a blinded examiner. The pain intensity, magnitude of disability, selfreporting functional limitations, quality of life and sagittal mobility of the trunk were assessed at the initial MDT session and at three and six weeks.
The demographic and patient-reported measures 
Outcome measures in the pilot trial
The recruitment rate per month, treatment sessions, and dropout rate were recorded. The compliance rate of wearing the LUMOback was defined as the 
Sample size estimation
Sandvik et al.
[16] recommended using 10 individuals for a pilot study; allowing for 10% of dropout, 11 patients were recruited for each group.
Randomization
Randomization was undertaken using sealed opaque envelopes, with concealed allocation maintained as patients selected an envelope with the intervention group. Patients were asked not to reveal their intervention group to the examiner for the sagittal mobility of the trunk.
Data analysis
The descriptive analysis was undertaken and mean (SD) or number (%) was calculated. For the outcome measures proposed for the full trial, the mean value of the GRCS was presented for each group at each follow-up along with the mean difference between the groups and its associated 95% confidence intervals (CIs). The mean value of the change from baseline to each follow-up and its mean difference between the groups with its associated 95% CIs was also calculated using descriptive analyses in other outcome measures proposed for the full trial.
RESULTS
Appendix 3 presented a flow-chart of the patients. Twenty-two participants were included in randomization over 20 months, and thus the recruitment rate per month was 1.1 patients per month. It was also estimated that 2.9 patients need to be assessed for eligibility to find one patient to be included in the study. Dropout rate was 9% at six weeks. Table 1 summarized the characteristics of the patients at baseline; and Table 2 presented the mean values and differences, with 95% CI, between groups at followups.
There was nobody who rated the GRCS≤2 in each follow-up. The mean (SD)
of the GRCS of the MDT group and MDT+LUMOback group were 4.7 (0.8) and 4.7
(0.5), respectively and its difference (95% CIs) between the groups was 0 (-0.6 to 0.6) at the 3-week follow-up. The mean (SD) of the GRCS of the MDT group and MDT+LUMOback group were equally 4.9 (0.5) and its difference (95% CIs) between the groups was 0 (-0.5 to 0.5) at the 6-week follow-up. Mean changes and differences (95% CI) between groups in other outcome measures are presented in Table 2 .
Appendix 4 presented the mean (SD) of the outcome measures proposed for the full trial except the GRCS at each follow-up.
The mean (SD) treatment sessions from the baseline to the 3-week follow-up undertake the exercises at all over three successive days. In the MDT+LUMOback group, the mean (SD) compliance rate of wearing the LUMOback was 88% (15%), where the mean (SD) posture score was 64% (14%). Table 3 demonstrated the phase of the MDT program at six weeks in both groups.
DISCUSSION
In the current study, the methods proposed to conduct the full RCT were piloted in: 1) recruitment rate per month, 2) treatment sessions, 3) compliance rate of wearing the LUMOback, 4) participants' adherence with treatment, 5) dropout rate and 6) MDT program at six weeks. It was also undertaken to make a preliminarily comparison of patient reported-outcomes between the MDT and MDT+LUMOback group and to estimate the variability of these outcomes.
The compliance rate of wearing the LUMOback was 88%, which indicates high compliance rate of the LUMOback. Patients in both groups undertook home exercises a mean of 3.7 sets per day. If 100% compliance was defined as 5 sets per day, the 3.7 sets per day was 74% compliance. Previously compliance rate of home exercise has been reported as about 60% [17] , with 80-90% rated as good adherence [18] .
Therefore, home exercise adherence can be considered acceptable. The dropout rate was 9%, which is also considered to be acceptable [19] . The MDT program at six weeks was mostly at the early phase of reducing derangement and there was nobody who was discharged from the intervention. In addition, the mean of the GRCS was 4.7 in each group. These findings suggest that six weeks would be reasonable as duration of the MDT intervention to compare the size of the treatment effect. There was nobody who rated the GRCS≤2 in each follow-up, which indicates that the method tested in the current study was safe and acceptable to the participants. The mean posture score of the MDT+LUMOback group over the 6-week intervention was 64%, which is similar
to those without a history of LBP in a previous study [4] . Therefore, it is assumed that postural correction had been successfully undertaken in the patients of the MDT+LUMOback group. These would all be positive findings of the current methods to progress to a full trial.
In contrast, negative findings of the current method to progress to a full trial were also detected. The recruitment rate was 1.1 patients per month, and it was estimated that 2.9 patients need to be assessed for eligibility to find one study patient.
Thus it would be expected that assessment of 180 patients would be required, and the recruitment process take five years to include 30 participants in each group. As the current pilot study was undertaken in a single orthopedic outpatient clinic with one therapist, a multi-center trial would be needed to generate a better recruitment rate. It should also be noted that there was not a placebo or no treatment control group, which might be unacceptable to those actively seeking treatment. However, a potential reason for the limited recruitment rate may be that patients in the current cohort had a lack of confidence to manipulate the wearable device.
A promising method for the full trial has been considered, but preliminarily data of the patient reported-outcomes between the MDT and MDT+LUMOback groups indicate a need to reconsider undertaking a full trial. All baseline measures did not seem comparable. For example, the FFD was not comparable, considering its minimum detectable change of 4.5cm [20] , which would not be surprising because of the small sample size. However, all measures demonstrated negligible mean difference between the groups at each follow-up, with 95% CIs that included zero. This indicates that any clinically important differences in the treatment effect are not likely to be detected between the MDT and MDT+LUMOback groups at least for six weeks.
Thus, rather than undertaking the full trial, a promising future research agenda may be: investigating patients' preference to keep using the LUMOback for their and without the use of a wearable device to manage habitual posture such as the LUMOback using a long-term follow-up. However, there is a lack of consensus about whether posture is actually a risk factor for LBP [5, 21, 22] .
Limitations
A limitation of the current study is that current data was contaminated by a selfselection bias. In particular, using the LUMOback might have been limited to patients who had an interest in, and expectations for, physical therapy interventions and technologies. It is known that patient expectations influence treatment effect [23], and that they are different between placebo-controlled clinical trials and clinical practice
[24]. The MDT+LUMOback group undertook interventions that were more than normal clinical practice, whereas the MDT group undertook interventions that were very close to clinical practice. It may be possible that the treatment effect in the current study was greater than other studies using MDT without cutting-edge interventions or placebocontrolled trials.
Another limitation is that reasons for the lack of group differences in the treatment effect are unclear due to the lack of LUMOback data in the MDT group. It 
